Sensitive ASX Announcement

Amplia Launches First Stage of Pivotal Narmafotinib Trial

Published: 19/05/26, 08:18am (AEST)2 pages
Amplia Therapeutics
ATX:ASXHealthcare

Recent ATX Announcements

Price Sensitive only